Bluefin Capital Management’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-23,200
Closed -$1K 611
2022
Q1
$1K Sell
23,200
-10,100
-30% -$29.3K ﹤0.01% 643
2021
Q4
$112K Sell
33,300
-171,400
-84% -$1.05M 0.01% 606
2021
Q3
$219K Sell
204,700
-28,200
-12% -$241K 0.02% 458
2021
Q2
$270K Buy
232,900
+167,100
+254% +$1.64M 0.02% 353
2021
Q1
$208K Buy
+65,800
New +$743K 0.01% 477

Other funds holding CLOV

Bluefin Capital Management's CLOV Position: Q2 2022 in Review

Bluefin Capital Management sold out of Clover Health Investments (CLOV) in Q2 2022, closing a stake of 57,207 shares — an estimated $152K sold.

Bluefin Capital Management first reported a position in CLOV in Q2 2020 and held it in 4 quarters. The position peaked at $1.96M in Q2 2020. 176 funds tracked by Wall St. Rank hold CLOV as of Q2 2022.

  • Bluefin Capital Management reported no remaining Clover Health Investments position as of Q2 2022 after selling out during the quarter.
  • Bluefin Capital Management sold 57,207 Clover Health Investments shares in Q2 2022, an estimated $152K.
  • Bluefin Capital Management first reported a position in Clover Health Investments in Q2 2020 and held it in 4 quarters.
  • Bluefin Capital Management's Clover Health Investments position peaked at $1.96M in Q2 2020.
  • 176 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2022.

Based on Bluefin Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.